Finally, NF-κB inhibitors are in development as possible therapies for asthma exacerbations, our data that IFN-α, IFN-β and IL-15 induction by RV are all NF-κB dependent suggest that such approaches may further impair already deficient responses in asthma. Here, IFNB1 is linked to asthma.